Signature Wealth Management Partners, LLC Tg Therapeutics, Inc. Transaction History
Signature Wealth Management Partners, LLC
- $172 Million
- Q2 2025
A detailed history of Signature Wealth Management Partners, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Signature Wealth Management Partners, LLC holds 10,780 shares of TGTX stock, worth $300,654. This represents 0.22% of its overall portfolio holdings.
Number of Shares
10,780
Previous 10,780
-0.0%
Holding current value
$300,654
Previous $425,000
8.94%
% of portfolio
0.22%
Previous 0.28%
Shares
4 transactions
Others Institutions Holding TGTX
# of Institutions
413Shares Held
87.9MCall Options Held
2.34MPut Options Held
1.93M-
Vanguard Group Inc Valley Forge, PA15.6MShares$435 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$318 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$207 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$97.3 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$79.4 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.05B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...